These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18456318)

  • 1. The structure analysis of Humanin analog, AGA-(C8R)HNG17, by circular dichroism and sedimentation equilibrium: comparison with the parent molecule.
    Arisaka F; Niikura T; Arakawa T; Kita Y
    Int J Biol Macromol; 2008 Aug; 43(2):88-93. PubMed ID: 18456318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The secondary structure analysis of a potent Ser14Gly analog of antiAlzheimer peptide, Humanin, by circular dichroism.
    Arakawa T; Niikura T; Tajima H; Kita Y
    J Pept Sci; 2006 Oct; 12(10):639-42. PubMed ID: 16835886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex structure transition of Humanin peptides by sodium dodecylsulfate and trifluoroethanol.
    Kita Y; Niikura T; Arisaka F; Arakawa T
    Protein Pept Lett; 2008; 15(5):510-5. PubMed ID: 18537742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity-dependent neurotrophic factor, ADNF, determines the structure characteristics of Colivelin, a fusion protein of ADNF9 and Humanin analog.
    Arakawa T; Niikura T; Arisaka F; Kita Y
    J Pept Sci; 2008 May; 14(5):631-6. PubMed ID: 17994638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanin Derivatives Inhibit Necrotic Cell Death in Neurons.
    Cohen A; Lerner-Yardeni J; Meridor D; Kasher R; Nathan I; Parola AH
    Mol Med; 2015 Jun; 21(1):505-14. PubMed ID: 26062019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biological activity of Humanin analogs correlates with structure stabilities in solution.
    Arakawa T; Niikura T; Kita Y
    Int J Biol Macromol; 2011 Jul; 49(1):93-7. PubMed ID: 21510972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of Ser14Gly-humanin, a potent rescue factor against neuronal cell death in Alzheimer's disease.
    Benaki D; Zikos C; Evangelou A; Livaniou E; Vlassi M; Mikros E; Pelecanou M
    Biochem Biophys Res Commun; 2006 Oct; 349(2):634-42. PubMed ID: 16945331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of three Humanin peptides with different activities upon interaction with liposome.
    Hirano A; Shiraki K; Niikura T; Arakawa T; Kita Y
    Int J Biol Macromol; 2011 Mar; 48(2):360-3. PubMed ID: 21215775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivo.
    Chiba T; Yamada M; Hashimoto Y; Sato M; Sasabe J; Kita Y; Terashita K; Aiso S; Nishimoto I; Matsuoka M
    J Neurosci; 2005 Nov; 25(44):10252-61. PubMed ID: 16267233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humanin structural versatility and interaction with model cerebral cortex membranes.
    Pistolesi S; Rossini L; Ferro E; Basosi R; Trabalzini L; Pogni R
    Biochemistry; 2009 Jun; 48(22):5026-33. PubMed ID: 19378954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanin and colivelin: neuronal-death-suppressing peptides for Alzheimer's disease and amyotrophic lateral sclerosis.
    Matsuoka M; Hashimoto Y; Aiso S; Nishimoto I
    CNS Drug Rev; 2006; 12(2):113-22. PubMed ID: 16958985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active form of neuroprotective Humanin, HN, and inactive analog, S7A-HN, are monomeric and disordered in aqueous phosphate solution at pH 6.0; No correlation of solution structure with activity.
    Arisaka F; Arakawa T; Niikura T; Kita Y
    Protein Pept Lett; 2009; 16(2):132-7. PubMed ID: 19200035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure changes of natively disordered Humanin in the presence of lipid.
    Hirano A; Shiraki K; Niikura T; Arakawa T; Kita Y
    Int J Biol Macromol; 2010 Apr; 46(3):375-9. PubMed ID: 20116397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short neuroprotective peptides, ADNF9 and NAP, are structurally disordered and monomeric in PBS.
    Arakawa T; Niikura T; Arisaka F; Kita Y
    Int J Biol Macromol; 2009 Jul; 45(1):8-11. PubMed ID: 19447252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CE study of neuroprotective humanin peptide and its derivatives: interactions with phosphate, sulphate, alkylsulphonates and sulphated-beta-CD.
    Havel J; Li R; Macka M
    Electrophoresis; 2008 Feb; 29(3):665-71. PubMed ID: 18203257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of humanin, a peptide against Alzheimer's disease-related neurotoxicity.
    Benaki D; Zikos C; Evangelou A; Livaniou E; Vlassi M; Mikros E; Pelecanou M
    Biochem Biophys Res Commun; 2005 Apr; 329(1):152-60. PubMed ID: 15721287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection against neurodegenerative diseases: development of a novel hybrid neuroprotective peptide Colivelin.
    Chiba T; Nishimoto I; Aiso S; Matsuoka M
    Mol Neurobiol; 2007 Feb; 35(1):55-84. PubMed ID: 17519506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.
    Romeo M; Stravalaci M; Beeg M; Rossi A; Fiordaliso F; Corbelli A; Salmona M; Gobbi M; Cagnotto A; Diomede L
    J Alzheimers Dis; 2017; 57(3):857-871. PubMed ID: 28282805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Ser-containing humanin shows promotion of fibril formation.
    Hayashi K; Sasabe J; Chiba T; Aiso S; Utsunomiya-Tate N
    Amino Acids; 2012 Jun; 42(6):2293-7. PubMed ID: 21735222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactive C8A‑humanin analog is as stable as a potent S14G‑humanin analog.
    Arakawa T; Niikura T; Kita Y
    Mol Med Rep; 2014 Jan; 9(1):375-9. PubMed ID: 24247787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.